Severe facial clefts in acrofacial dysostosis: A consequence of prenatal exposure to mycophenolate mofetil?

Obstetrics and Gynecology

Volumn 111, Issue 2 PART 2, 2008, Pages 483-486

  Schoner, Katharina ^b   Steinhard, Johannes ^b   Figiel, Jens ^b   Rehder, Helga ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ARTICLE; CARDIOVASCULAR MALFORMATION; CASE REPORT; FACE MALFORMATION; FACIAL CLEFT; FEMALE; FETUS; GASTROINTESTINAL MALFORMATION; HUMAN; LIMB MALFORMATION; NAGER ACROFACIAL DYSOSTOSIS; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TERATOGENICITY; UROGENITAL TRACT MALFORMATION;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; CRANIOFACIAL ABNORMALITIES; FEMALE; FETAL DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYCOPHENOLIC ACID; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 38549092517     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000298347.18812.a4     Document Type: Article

References (10)

1. Sifontis NM, Coscia LA, Constantinescu S, Lavelanet AF, Moritz MJ, Armenti VT. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 2006;82:1698-702.
2. Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH. The safety of 6-mercapto-purine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 2003;124:9-17.
3. Cararach V, Carmona F, Monleon FJ, Andreu J. Pregnancy after renal transplantation: 25 years experience in Spain. Br J Obstet Gynaecol 1993;100:122-5.
4. Tendron A, Gouyon JB, Decramer S. In utero exposure to immunosuppressive drugs: experimental and clinical studies. Pediatr Nephrol 2002;17:121-30.
5. Pergola PE, Kancharla A, Riley DJ. Kidney transplantation during first trimester of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone. Transplantation 2001;71:994-7.
6. Le Ray C, Coulomb A, Elefant E, Frydman R, Audibert F. Mycophenolate Mofetil in Pregnancy after renal transplantation: a case of major fetal malformations. Obstet Gynecol 2004;103:1091-4.
7. Tjeertes IF, Bastiaans DE, van Ganzewinkel CJ, Zegers SH. Neonatal anemia and hydrops fetalis after maternal mycophenolate mofetil use. J Perinatol 2007;27:62-4.
8. Källen B, Westgren M, Åberg A, Olausson PO. Pregnancy outcome after maternal organ transplantation in Sweden. BJOG 2005;112:904-9.
9. Winter RM, Baraitser M. Oxford Medical Databases: London Dysmorphology Database, Version 3.0-Dysmorphology Photo Library on CD-ROM Version 3.0. London (UK): Oxford University Press; 2001.
10. Velinov M, Zellers N. The fetal mycophenolate mofetil syndrome. Clin Dysmorphol 2008;17:77-8.